Endocrine Disorders
Spruce Biosciences Inc. focuses on classic congenital adrenal hyperplasia, with clinical research centered on the hormonal and metabolic consequences of this inherited endocrine disorder.
- Congenital adrenal hyperplasia
- Adrenal hormone imbalance
- Glucocorticoid-related management
Its research activity is directed toward patients with persistent adrenal steroid dysregulation and elevated blood hormone levels associated with this condition.
Hormonal Biomarker Modulation
The sponsor’s studies examine therapeutic interest in reducing excess androstenedione and adjusting glucocorticoid burden in adults living with classic CAH.
- Androstenedione reduction
- Glucocorticoid sparing
- Blood hormone control
This places emphasis on managing the biochemical features that define the disorder rather than broader multisystem disease areas.
Rare Disease Therapeutics
Spruce Biosciences is active in the rare disease space, with research concentrated on a narrowly defined patient population affected by a lifelong adrenal condition.
- Rare endocrine disease
- Adult congenital adrenal hyperplasia
- Inherited adrenal conditions
The funded trials reflect interest in therapeutic options for a specialized population with limited treatment-focused research.
Adrenal Steroid Regulation
Clinical research activity includes attention to adrenal steroid regulation and the control of hormone excess linked to classic CAH.
- Adrenal steroid excess
- Hormone suppression
- Endocrine homeostasis
These studies align with therapeutic interest in improving biochemical control in patients with chronic adrenal hormone abnormalities.
